Document VJRazm06XKKqjNj95JpZ2va4j

DRAFT CINPATHOGEN DELIVERABLES d. Cases of lymphoid neoplasms will be accrued until December 31 , 2007 2. A benzene exposure assessment matrix for all study cases and controls. The matrix will consider job, industry and time period in developing exposure estimates to benzene. Data sources for exposure assessment including the IPHS data set, Yang Pu database, the Chinese literature, real-time monitoring in selected factories and simulations will be used to arrive at credible benzene exposure estimates. 3. A substantial preliminary data set (including AMLs and lymphoid neoplasms by WHO criteria, confounders and the exposure assessment matri~~~Qr testing the case- control protocol to Applied Health Science by Septemb~~~~07*. [No ICD-9 classifications are being delivered for the case-contr~!~~~ay.] 4. YE07 progress report "iiiii"::'I:::II~~!'I~~ms diagnosis 5. A final data set (including all cases of during the study by WHO criteria, for completion of the case-control 2008*. [No ICD-9 classifications are and the exposureij~~essment matrix) Scienc~~~y June the case-conW~!study.] *Based on a timeline agreed upon in Otto Wong. QA/QC team and Dr. Disease Progression Studies 1. of the Disease Progression March 18, 2007 Molecular 1. the findings of the Molecular , 2008 following guidelines in Cinpathogen's Section 3.1-A. 1. conditions in the agreement for advance funding for to Richard Irons, April 11, 2007). Deliverable date or 2. of recommendations from the independent QA/QC team. Deliverable date or progress report expectation 3. 4. Update of estimated NHL case numbers per ICD-9 classification in May 2007. Periodic updates throughout 2007 linked to diagnostic reviews which are on a nominal quarterly basis (approximately July, October, and January 2008.) [I would recommend dropping this deliverable and instead request updates based on lymphoid neoplasms with documented informed consents and work history questionnaire administration for all cases and controls.] 2 SHELL-MCCLURG-059717